Effect of atropine eye drop for inhibition of myopic progressio
Phase 3
Recruiting
- Conditions
- Inhibition of myopic progression with using atropine eye drop.Myopia
- Registration Number
- IRCT20100414003714N3
- Lead Sponsor
- Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
aged 6-18
Myopia astigmatism (2-6 diopter)
No amblyopia
Exclusion Criteria
Age under 6 and over 18
Amblyopia
Strabismus
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent of myopic power and axial length changes. Timepoint: 6 months after discontinuation of atropine 0.1% and 0.01% eye drop and placebo. Method of measurement: Auto refractometer and ultrasound.
- Secondary Outcome Measures
Name Time Method Myopic power and axial length changes 6 months after treatment withdrawal. Timepoint: 6 months after discontinuation of atropine 0.1% and 0.01% eye drop and. Method of measurement: Auto refractometer and ultrasound.